Global Photodynamic Therapy Drugs (PTD) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Photodynamic Therapy Drugs (PTD) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 109

Published Date: 22 Apr 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

Photodynamic therapy drugs (PTD) are photosensitizing agents used in photodynamic therapy, a non-invasive medical treatment that involves the administration of light-sensitive drugs followed by exposure to specific wavelengths of light to target and destroy abnormal cells, such as cancer cells or skin lesions.

According to our (Global Info Research) latest study, the global Photodynamic Therapy Drugs (PTD) market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global Photodynamic Therapy Drugs (PTD) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Photodynamic Therapy Drugs (PTD) market size and forecasts, in consumption value ($ Million), 2019-2030
Global Photodynamic Therapy Drugs (PTD) market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Photodynamic Therapy Drugs (PTD) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Photodynamic Therapy Drugs (PTD) market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Photodynamic Therapy Drugs (PTD)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Photodynamic Therapy Drugs (PTD) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include DUSA Pharmaceuticals, Soligenix, ORALIA, Theralase, Quest Pharmatech, Biofrontera, Merck, QIYUE BIOLOGY, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical, Shanghai Guangsheng Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Photodynamic Therapy Drugs (PTD) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation
Photodynamic Therapy Drugs (PTD) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Aminolevulinic Acid
Hemoporfin
Sinoporphyrin Sodium
Others

Market segment by Application
Pancreatic Cancer
Esophageal Cancer
Skin Cancer
Lung Cancer
Others

Market segment by players, this report covers
DUSA Pharmaceuticals
Soligenix
ORALIA
Theralase
Quest Pharmatech
Biofrontera
Merck
QIYUE BIOLOGY
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
Shanghai Guangsheng Pharmaceutical
APExBIO Technology
Thermo Fisher

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Photodynamic Therapy Drugs (PTD) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Photodynamic Therapy Drugs (PTD), with revenue, gross margin, and global market share of Photodynamic Therapy Drugs (PTD) from 2019 to 2024.
Chapter 3, the Photodynamic Therapy Drugs (PTD) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Photodynamic Therapy Drugs (PTD) market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Photodynamic Therapy Drugs (PTD).
Chapter 13, to describe Photodynamic Therapy Drugs (PTD) research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Photodynamic Therapy Drugs (PTD) by Type
1.3.1 Overview: Global Photodynamic Therapy Drugs (PTD) Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Type in 2023
1.3.3 Aminolevulinic Acid
1.3.4 Hemoporfin
1.3.5 Sinoporphyrin Sodium
1.3.6 Others
1.4 Global Photodynamic Therapy Drugs (PTD) Market by Application
1.4.1 Overview: Global Photodynamic Therapy Drugs (PTD) Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pancreatic Cancer
1.4.3 Esophageal Cancer
1.4.4 Skin Cancer
1.4.5 Lung Cancer
1.4.6 Others
1.5 Global Photodynamic Therapy Drugs (PTD) Market Size & Forecast
1.6 Global Photodynamic Therapy Drugs (PTD) Market Size and Forecast by Region
1.6.1 Global Photodynamic Therapy Drugs (PTD) Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Photodynamic Therapy Drugs (PTD) Market Size by Region, (2019-2030)
1.6.3 North America Photodynamic Therapy Drugs (PTD) Market Size and Prospect (2019-2030)
1.6.4 Europe Photodynamic Therapy Drugs (PTD) Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Size and Prospect (2019-2030)
1.6.6 South America Photodynamic Therapy Drugs (PTD) Market Size and Prospect (2019-2030)
1.6.7 Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Size and Prospect (2019-2030)

2 Company Profiles
2.1 DUSA Pharmaceuticals
2.1.1 DUSA Pharmaceuticals Details
2.1.2 DUSA Pharmaceuticals Major Business
2.1.3 DUSA Pharmaceuticals Photodynamic Therapy Drugs (PTD) Product and Solutions
2.1.4 DUSA Pharmaceuticals Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 DUSA Pharmaceuticals Recent Developments and Future Plans
2.2 Soligenix
2.2.1 Soligenix Details
2.2.2 Soligenix Major Business
2.2.3 Soligenix Photodynamic Therapy Drugs (PTD) Product and Solutions
2.2.4 Soligenix Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Soligenix Recent Developments and Future Plans
2.3 ORALIA
2.3.1 ORALIA Details
2.3.2 ORALIA Major Business
2.3.3 ORALIA Photodynamic Therapy Drugs (PTD) Product and Solutions
2.3.4 ORALIA Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 ORALIA Recent Developments and Future Plans
2.4 Theralase
2.4.1 Theralase Details
2.4.2 Theralase Major Business
2.4.3 Theralase Photodynamic Therapy Drugs (PTD) Product and Solutions
2.4.4 Theralase Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Theralase Recent Developments and Future Plans
2.5 Quest Pharmatech
2.5.1 Quest Pharmatech Details
2.5.2 Quest Pharmatech Major Business
2.5.3 Quest Pharmatech Photodynamic Therapy Drugs (PTD) Product and Solutions
2.5.4 Quest Pharmatech Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Quest Pharmatech Recent Developments and Future Plans
2.6 Biofrontera
2.6.1 Biofrontera Details
2.6.2 Biofrontera Major Business
2.6.3 Biofrontera Photodynamic Therapy Drugs (PTD) Product and Solutions
2.6.4 Biofrontera Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Biofrontera Recent Developments and Future Plans
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Photodynamic Therapy Drugs (PTD) Product and Solutions
2.7.4 Merck Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Merck Recent Developments and Future Plans
2.8 QIYUE BIOLOGY
2.8.1 QIYUE BIOLOGY Details
2.8.2 QIYUE BIOLOGY Major Business
2.8.3 QIYUE BIOLOGY Photodynamic Therapy Drugs (PTD) Product and Solutions
2.8.4 QIYUE BIOLOGY Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 QIYUE BIOLOGY Recent Developments and Future Plans
2.9 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
2.9.1 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Details
2.9.2 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Major Business
2.9.3 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Photodynamic Therapy Drugs (PTD) Product and Solutions
2.9.4 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Recent Developments and Future Plans
2.10 Shanghai Guangsheng Pharmaceutical
2.10.1 Shanghai Guangsheng Pharmaceutical Details
2.10.2 Shanghai Guangsheng Pharmaceutical Major Business
2.10.3 Shanghai Guangsheng Pharmaceutical Photodynamic Therapy Drugs (PTD) Product and Solutions
2.10.4 Shanghai Guangsheng Pharmaceutical Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Shanghai Guangsheng Pharmaceutical Recent Developments and Future Plans
2.11 APExBIO Technology
2.11.1 APExBIO Technology Details
2.11.2 APExBIO Technology Major Business
2.11.3 APExBIO Technology Photodynamic Therapy Drugs (PTD) Product and Solutions
2.11.4 APExBIO Technology Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 APExBIO Technology Recent Developments and Future Plans
2.12 Thermo Fisher
2.12.1 Thermo Fisher Details
2.12.2 Thermo Fisher Major Business
2.12.3 Thermo Fisher Photodynamic Therapy Drugs (PTD) Product and Solutions
2.12.4 Thermo Fisher Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Thermo Fisher Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Photodynamic Therapy Drugs (PTD) Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Photodynamic Therapy Drugs (PTD) by Company Revenue
3.2.2 Top 3 Photodynamic Therapy Drugs (PTD) Players Market Share in 2023
3.2.3 Top 6 Photodynamic Therapy Drugs (PTD) Players Market Share in 2023
3.3 Photodynamic Therapy Drugs (PTD) Market: Overall Company Footprint Analysis
3.3.1 Photodynamic Therapy Drugs (PTD) Market: Region Footprint
3.3.2 Photodynamic Therapy Drugs (PTD) Market: Company Product Type Footprint
3.3.3 Photodynamic Therapy Drugs (PTD) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
4.1 Global Photodynamic Therapy Drugs (PTD) Consumption Value and Market Share by Type (2019-2024)
4.2 Global Photodynamic Therapy Drugs (PTD) Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
5.1 Global Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Application (2019-2024)
5.2 Global Photodynamic Therapy Drugs (PTD) Market Forecast by Application (2025-2030)

6 North America
6.1 North America Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2019-2030)
6.2 North America Photodynamic Therapy Drugs (PTD) Market Size by Application (2019-2030)
6.3 North America Photodynamic Therapy Drugs (PTD) Market Size by Country
6.3.1 North America Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2019-2030)
6.3.2 United States Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
6.3.3 Canada Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
6.3.4 Mexico Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)

7 Europe
7.1 Europe Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2019-2030)
7.2 Europe Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2019-2030)
7.3 Europe Photodynamic Therapy Drugs (PTD) Market Size by Country
7.3.1 Europe Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2019-2030)
7.3.2 Germany Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
7.3.3 France Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
7.3.5 Russia Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
7.3.6 Italy Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)

8 Asia-Pacific
8.1 Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Size by Region
8.3.1 Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value by Region (2019-2030)
8.3.2 China Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
8.3.3 Japan Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
8.3.4 South Korea Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
8.3.5 India Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
8.3.7 Australia Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)

9 South America
9.1 South America Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2019-2030)
9.2 South America Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2019-2030)
9.3 South America Photodynamic Therapy Drugs (PTD) Market Size by Country
9.3.1 South America Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2019-2030)
9.3.2 Brazil Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
9.3.3 Argentina Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)

10 Middle East & Africa
10.1 Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Size by Country
10.3.1 Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2019-2030)
10.3.2 Turkey Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
10.3.4 UAE Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)

11 Market Dynamics
11.1 Photodynamic Therapy Drugs (PTD) Market Drivers
11.2 Photodynamic Therapy Drugs (PTD) Market Restraints
11.3 Photodynamic Therapy Drugs (PTD) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry

12 Industry Chain Analysis
12.1 Photodynamic Therapy Drugs (PTD) Industry Chain
12.2 Photodynamic Therapy Drugs (PTD) Upstream Analysis
12.3 Photodynamic Therapy Drugs (PTD) Midstream Analysis
12.4 Photodynamic Therapy Drugs (PTD) Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Photodynamic Therapy Drugs (PTD) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Photodynamic Therapy Drugs (PTD) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Photodynamic Therapy Drugs (PTD) Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Photodynamic Therapy Drugs (PTD) Consumption Value by Region (2025-2030) & (USD Million)
Table 5. DUSA Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 6. DUSA Pharmaceuticals Major Business
Table 7. DUSA Pharmaceuticals Photodynamic Therapy Drugs (PTD) Product and Solutions
Table 8. DUSA Pharmaceuticals Photodynamic Therapy Drugs (PTD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. DUSA Pharmaceuticals Recent Developments and Future Plans
Table 10. Soligenix Company Information, Head Office, and Major Competitors
Table 11. Soligenix Major Business
Table 12. Soligenix Photodynamic Therapy Drugs (PTD) Product and Solutions
Table 13. Soligenix Photodynamic Therapy Drugs (PTD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Soligenix Recent Developments and Future Plans
Table 15. ORALIA Company Information, Head Office, and Major Competitors
Table 16. ORALIA Major Business
Table 17. ORALIA Photodynamic Therapy Drugs (PTD) Product and Solutions
Table 18. ORALIA Photodynamic Therapy Drugs (PTD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Theralase Company Information, Head Office, and Major Competitors
Table 20. Theralase Major Business
Table 21. Theralase Photodynamic Therapy Drugs (PTD) Product and Solutions
Table 22. Theralase Photodynamic Therapy Drugs (PTD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 23. Theralase Recent Developments and Future Plans
Table 24. Quest Pharmatech Company Information, Head Office, and Major Competitors
Table 25. Quest Pharmatech Major Business
Table 26. Quest Pharmatech Photodynamic Therapy Drugs (PTD) Product and Solutions
Table 27. Quest Pharmatech Photodynamic Therapy Drugs (PTD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 28. Quest Pharmatech Recent Developments and Future Plans
Table 29. Biofrontera Company Information, Head Office, and Major Competitors
Table 30. Biofrontera Major Business
Table 31. Biofrontera Photodynamic Therapy Drugs (PTD) Product and Solutions
Table 32. Biofrontera Photodynamic Therapy Drugs (PTD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 33. Biofrontera Recent Developments and Future Plans
Table 34. Merck Company Information, Head Office, and Major Competitors
Table 35. Merck Major Business
Table 36. Merck Photodynamic Therapy Drugs (PTD) Product and Solutions
Table 37. Merck Photodynamic Therapy Drugs (PTD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 38. Merck Recent Developments and Future Plans
Table 39. QIYUE BIOLOGY Company Information, Head Office, and Major Competitors
Table 40. QIYUE BIOLOGY Major Business
Table 41. QIYUE BIOLOGY Photodynamic Therapy Drugs (PTD) Product and Solutions
Table 42. QIYUE BIOLOGY Photodynamic Therapy Drugs (PTD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 43. QIYUE BIOLOGY Recent Developments and Future Plans
Table 44. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Company Information, Head Office, and Major Competitors
Table 45. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Major Business
Table 46. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Photodynamic Therapy Drugs (PTD) Product and Solutions
Table 47. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Photodynamic Therapy Drugs (PTD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 48. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Recent Developments and Future Plans
Table 49. Shanghai Guangsheng Pharmaceutical Company Information, Head Office, and Major Competitors
Table 50. Shanghai Guangsheng Pharmaceutical Major Business
Table 51. Shanghai Guangsheng Pharmaceutical Photodynamic Therapy Drugs (PTD) Product and Solutions
Table 52. Shanghai Guangsheng Pharmaceutical Photodynamic Therapy Drugs (PTD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 53. Shanghai Guangsheng Pharmaceutical Recent Developments and Future Plans
Table 54. APExBIO Technology Company Information, Head Office, and Major Competitors
Table 55. APExBIO Technology Major Business
Table 56. APExBIO Technology Photodynamic Therapy Drugs (PTD) Product and Solutions
Table 57. APExBIO Technology Photodynamic Therapy Drugs (PTD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 58. APExBIO Technology Recent Developments and Future Plans
Table 59. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 60. Thermo Fisher Major Business
Table 61. Thermo Fisher Photodynamic Therapy Drugs (PTD) Product and Solutions
Table 62. Thermo Fisher Photodynamic Therapy Drugs (PTD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 63. Thermo Fisher Recent Developments and Future Plans
Table 64. Global Photodynamic Therapy Drugs (PTD) Revenue (USD Million) by Players (2019-2024)
Table 65. Global Photodynamic Therapy Drugs (PTD) Revenue Share by Players (2019-2024)
Table 66. Breakdown of Photodynamic Therapy Drugs (PTD) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 67. Market Position of Players in Photodynamic Therapy Drugs (PTD), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 68. Head Office of Key Photodynamic Therapy Drugs (PTD) Players
Table 69. Photodynamic Therapy Drugs (PTD) Market: Company Product Type Footprint
Table 70. Photodynamic Therapy Drugs (PTD) Market: Company Product Application Footprint
Table 71. Photodynamic Therapy Drugs (PTD) New Market Entrants and Barriers to Market Entry
Table 72. Photodynamic Therapy Drugs (PTD) Mergers, Acquisition, Agreements, and Collaborations
Table 73. Global Photodynamic Therapy Drugs (PTD) Consumption Value (USD Million) by Type (2019-2024)
Table 74. Global Photodynamic Therapy Drugs (PTD) Consumption Value Share by Type (2019-2024)
Table 75. Global Photodynamic Therapy Drugs (PTD) Consumption Value Forecast by Type (2025-2030)
Table 76. Global Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2019-2024)
Table 77. Global Photodynamic Therapy Drugs (PTD) Consumption Value Forecast by Application (2025-2030)
Table 78. North America Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2019-2024) & (USD Million)
Table 79. North America Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2025-2030) & (USD Million)
Table 80. North America Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2019-2024) & (USD Million)
Table 81. North America Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2025-2030) & (USD Million)
Table 82. North America Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2019-2024) & (USD Million)
Table 83. North America Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2025-2030) & (USD Million)
Table 84. Europe Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2019-2024) & (USD Million)
Table 85. Europe Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2025-2030) & (USD Million)
Table 86. Europe Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2019-2024) & (USD Million)
Table 87. Europe Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2025-2030) & (USD Million)
Table 88. Europe Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2019-2024) & (USD Million)
Table 89. Europe Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2025-2030) & (USD Million)
Table 90. Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2019-2024) & (USD Million)
Table 91. Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2025-2030) & (USD Million)
Table 92. Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2019-2024) & (USD Million)
Table 93. Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2025-2030) & (USD Million)
Table 94. Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value by Region (2019-2024) & (USD Million)
Table 95. Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value by Region (2025-2030) & (USD Million)
Table 96. South America Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2019-2024) & (USD Million)
Table 97. South America Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2025-2030) & (USD Million)
Table 98. South America Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2019-2024) & (USD Million)
Table 99. South America Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2025-2030) & (USD Million)
Table 100. South America Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2019-2024) & (USD Million)
Table 101. South America Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2025-2030) & (USD Million)
Table 102. Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2019-2024) & (USD Million)
Table 103. Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2025-2030) & (USD Million)
Table 104. Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2019-2024) & (USD Million)
Table 105. Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2025-2030) & (USD Million)
Table 106. Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2019-2024) & (USD Million)
Table 107. Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Global Key Players of Photodynamic Therapy Drugs (PTD) Upstream (Raw Materials)
Table 109. Global Photodynamic Therapy Drugs (PTD) Typical Customers


List of Figures
Figure 1. Photodynamic Therapy Drugs (PTD) Picture
Figure 2. Global Photodynamic Therapy Drugs (PTD) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Type in 2023
Figure 4. Aminolevulinic Acid
Figure 5. Hemoporfin
Figure 6. Sinoporphyrin Sodium
Figure 7. Others
Figure 8. Global Photodynamic Therapy Drugs (PTD) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Application in 2023
Figure 10. Pancreatic Cancer Picture
Figure 11. Esophageal Cancer Picture
Figure 12. Skin Cancer Picture
Figure 13. Lung Cancer Picture
Figure 14. Others Picture
Figure 15. Global Photodynamic Therapy Drugs (PTD) Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global Photodynamic Therapy Drugs (PTD) Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global Market Photodynamic Therapy Drugs (PTD) Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
Figure 18. Global Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Region (2019-2030)
Figure 19. Global Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Region in 2023
Figure 20. North America Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 21. Europe Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 22. Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 23. South America Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 24. Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 25. Company Three Recent Developments and Future Plans
Figure 26. Global Photodynamic Therapy Drugs (PTD) Revenue Share by Players in 2023
Figure 27. Photodynamic Therapy Drugs (PTD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
Figure 28. Market Share of Photodynamic Therapy Drugs (PTD) by Player Revenue in 2023
Figure 29. Top 3 Photodynamic Therapy Drugs (PTD) Players Market Share in 2023
Figure 30. Top 6 Photodynamic Therapy Drugs (PTD) Players Market Share in 2023
Figure 31. Global Photodynamic Therapy Drugs (PTD) Consumption Value Share by Type (2019-2024)
Figure 32. Global Photodynamic Therapy Drugs (PTD) Market Share Forecast by Type (2025-2030)
Figure 33. Global Photodynamic Therapy Drugs (PTD) Consumption Value Share by Application (2019-2024)
Figure 34. Global Photodynamic Therapy Drugs (PTD) Market Share Forecast by Application (2025-2030)
Figure 35. North America Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Type (2019-2030)
Figure 36. North America Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Application (2019-2030)
Figure 37. North America Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 39. Canada Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 40. Mexico Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 41. Europe Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Type (2019-2030)
Figure 42. Europe Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Application (2019-2030)
Figure 43. Europe Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 45. France Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 46. United Kingdom Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 47. Russia Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 48. Italy Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Region (2019-2030)
Figure 52. China Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 53. Japan Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 54. South Korea Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 55. India Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 56. Southeast Asia Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 57. Australia Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 58. South America Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Type (2019-2030)
Figure 59. South America Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Application (2019-2030)
Figure 60. South America Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Country (2019-2030)
Figure 61. Brazil Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 62. Argentina Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 63. Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Type (2019-2030)
Figure 64. Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Application (2019-2030)
Figure 65. Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Country (2019-2030)
Figure 66. Turkey Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 67. Saudi Arabia Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 68. UAE Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 69. Photodynamic Therapy Drugs (PTD) Market Drivers
Figure 70. Photodynamic Therapy Drugs (PTD) Market Restraints
Figure 71. Photodynamic Therapy Drugs (PTD) Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Photodynamic Therapy Drugs (PTD) Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

DUSA Pharmaceuticals
Soligenix
ORALIA
Theralase
Quest Pharmatech
Biofrontera
Merck
QIYUE BIOLOGY
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
Shanghai Guangsheng Pharmaceutical
APExBIO Technology
Thermo Fisher
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Photodynamic Therapy Drugs (PTD) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Photodynamic Therapy Drugs (PTD) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 109

Published Date: 22 Apr 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

Photodynamic therapy drugs (PTD) are photosensitizing agents used in photodynamic therapy, a non-invasive medical treatment that involves the administration of light-sensitive drugs followed by exposure to specific wavelengths of light to target and destroy abnormal cells, such as cancer cells or skin lesions.

According to our (Global Info Research) latest study, the global Photodynamic Therapy Drugs (PTD) market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global Photodynamic Therapy Drugs (PTD) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Photodynamic Therapy Drugs (PTD) market size and forecasts, in consumption value ($ Million), 2019-2030
Global Photodynamic Therapy Drugs (PTD) market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Photodynamic Therapy Drugs (PTD) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Photodynamic Therapy Drugs (PTD) market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Photodynamic Therapy Drugs (PTD)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Photodynamic Therapy Drugs (PTD) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include DUSA Pharmaceuticals, Soligenix, ORALIA, Theralase, Quest Pharmatech, Biofrontera, Merck, QIYUE BIOLOGY, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical, Shanghai Guangsheng Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Photodynamic Therapy Drugs (PTD) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation
Photodynamic Therapy Drugs (PTD) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Aminolevulinic Acid
Hemoporfin
Sinoporphyrin Sodium
Others

Market segment by Application
Pancreatic Cancer
Esophageal Cancer
Skin Cancer
Lung Cancer
Others

Market segment by players, this report covers
DUSA Pharmaceuticals
Soligenix
ORALIA
Theralase
Quest Pharmatech
Biofrontera
Merck
QIYUE BIOLOGY
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
Shanghai Guangsheng Pharmaceutical
APExBIO Technology
Thermo Fisher

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Photodynamic Therapy Drugs (PTD) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Photodynamic Therapy Drugs (PTD), with revenue, gross margin, and global market share of Photodynamic Therapy Drugs (PTD) from 2019 to 2024.
Chapter 3, the Photodynamic Therapy Drugs (PTD) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Photodynamic Therapy Drugs (PTD) market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Photodynamic Therapy Drugs (PTD).
Chapter 13, to describe Photodynamic Therapy Drugs (PTD) research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Photodynamic Therapy Drugs (PTD) by Type
1.3.1 Overview: Global Photodynamic Therapy Drugs (PTD) Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Type in 2023
1.3.3 Aminolevulinic Acid
1.3.4 Hemoporfin
1.3.5 Sinoporphyrin Sodium
1.3.6 Others
1.4 Global Photodynamic Therapy Drugs (PTD) Market by Application
1.4.1 Overview: Global Photodynamic Therapy Drugs (PTD) Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pancreatic Cancer
1.4.3 Esophageal Cancer
1.4.4 Skin Cancer
1.4.5 Lung Cancer
1.4.6 Others
1.5 Global Photodynamic Therapy Drugs (PTD) Market Size & Forecast
1.6 Global Photodynamic Therapy Drugs (PTD) Market Size and Forecast by Region
1.6.1 Global Photodynamic Therapy Drugs (PTD) Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Photodynamic Therapy Drugs (PTD) Market Size by Region, (2019-2030)
1.6.3 North America Photodynamic Therapy Drugs (PTD) Market Size and Prospect (2019-2030)
1.6.4 Europe Photodynamic Therapy Drugs (PTD) Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Size and Prospect (2019-2030)
1.6.6 South America Photodynamic Therapy Drugs (PTD) Market Size and Prospect (2019-2030)
1.6.7 Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Size and Prospect (2019-2030)

2 Company Profiles
2.1 DUSA Pharmaceuticals
2.1.1 DUSA Pharmaceuticals Details
2.1.2 DUSA Pharmaceuticals Major Business
2.1.3 DUSA Pharmaceuticals Photodynamic Therapy Drugs (PTD) Product and Solutions
2.1.4 DUSA Pharmaceuticals Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 DUSA Pharmaceuticals Recent Developments and Future Plans
2.2 Soligenix
2.2.1 Soligenix Details
2.2.2 Soligenix Major Business
2.2.3 Soligenix Photodynamic Therapy Drugs (PTD) Product and Solutions
2.2.4 Soligenix Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Soligenix Recent Developments and Future Plans
2.3 ORALIA
2.3.1 ORALIA Details
2.3.2 ORALIA Major Business
2.3.3 ORALIA Photodynamic Therapy Drugs (PTD) Product and Solutions
2.3.4 ORALIA Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 ORALIA Recent Developments and Future Plans
2.4 Theralase
2.4.1 Theralase Details
2.4.2 Theralase Major Business
2.4.3 Theralase Photodynamic Therapy Drugs (PTD) Product and Solutions
2.4.4 Theralase Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Theralase Recent Developments and Future Plans
2.5 Quest Pharmatech
2.5.1 Quest Pharmatech Details
2.5.2 Quest Pharmatech Major Business
2.5.3 Quest Pharmatech Photodynamic Therapy Drugs (PTD) Product and Solutions
2.5.4 Quest Pharmatech Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Quest Pharmatech Recent Developments and Future Plans
2.6 Biofrontera
2.6.1 Biofrontera Details
2.6.2 Biofrontera Major Business
2.6.3 Biofrontera Photodynamic Therapy Drugs (PTD) Product and Solutions
2.6.4 Biofrontera Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Biofrontera Recent Developments and Future Plans
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Photodynamic Therapy Drugs (PTD) Product and Solutions
2.7.4 Merck Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Merck Recent Developments and Future Plans
2.8 QIYUE BIOLOGY
2.8.1 QIYUE BIOLOGY Details
2.8.2 QIYUE BIOLOGY Major Business
2.8.3 QIYUE BIOLOGY Photodynamic Therapy Drugs (PTD) Product and Solutions
2.8.4 QIYUE BIOLOGY Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 QIYUE BIOLOGY Recent Developments and Future Plans
2.9 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
2.9.1 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Details
2.9.2 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Major Business
2.9.3 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Photodynamic Therapy Drugs (PTD) Product and Solutions
2.9.4 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Recent Developments and Future Plans
2.10 Shanghai Guangsheng Pharmaceutical
2.10.1 Shanghai Guangsheng Pharmaceutical Details
2.10.2 Shanghai Guangsheng Pharmaceutical Major Business
2.10.3 Shanghai Guangsheng Pharmaceutical Photodynamic Therapy Drugs (PTD) Product and Solutions
2.10.4 Shanghai Guangsheng Pharmaceutical Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Shanghai Guangsheng Pharmaceutical Recent Developments and Future Plans
2.11 APExBIO Technology
2.11.1 APExBIO Technology Details
2.11.2 APExBIO Technology Major Business
2.11.3 APExBIO Technology Photodynamic Therapy Drugs (PTD) Product and Solutions
2.11.4 APExBIO Technology Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 APExBIO Technology Recent Developments and Future Plans
2.12 Thermo Fisher
2.12.1 Thermo Fisher Details
2.12.2 Thermo Fisher Major Business
2.12.3 Thermo Fisher Photodynamic Therapy Drugs (PTD) Product and Solutions
2.12.4 Thermo Fisher Photodynamic Therapy Drugs (PTD) Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Thermo Fisher Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Photodynamic Therapy Drugs (PTD) Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Photodynamic Therapy Drugs (PTD) by Company Revenue
3.2.2 Top 3 Photodynamic Therapy Drugs (PTD) Players Market Share in 2023
3.2.3 Top 6 Photodynamic Therapy Drugs (PTD) Players Market Share in 2023
3.3 Photodynamic Therapy Drugs (PTD) Market: Overall Company Footprint Analysis
3.3.1 Photodynamic Therapy Drugs (PTD) Market: Region Footprint
3.3.2 Photodynamic Therapy Drugs (PTD) Market: Company Product Type Footprint
3.3.3 Photodynamic Therapy Drugs (PTD) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
4.1 Global Photodynamic Therapy Drugs (PTD) Consumption Value and Market Share by Type (2019-2024)
4.2 Global Photodynamic Therapy Drugs (PTD) Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
5.1 Global Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Application (2019-2024)
5.2 Global Photodynamic Therapy Drugs (PTD) Market Forecast by Application (2025-2030)

6 North America
6.1 North America Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2019-2030)
6.2 North America Photodynamic Therapy Drugs (PTD) Market Size by Application (2019-2030)
6.3 North America Photodynamic Therapy Drugs (PTD) Market Size by Country
6.3.1 North America Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2019-2030)
6.3.2 United States Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
6.3.3 Canada Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
6.3.4 Mexico Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)

7 Europe
7.1 Europe Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2019-2030)
7.2 Europe Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2019-2030)
7.3 Europe Photodynamic Therapy Drugs (PTD) Market Size by Country
7.3.1 Europe Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2019-2030)
7.3.2 Germany Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
7.3.3 France Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
7.3.5 Russia Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
7.3.6 Italy Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)

8 Asia-Pacific
8.1 Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Photodynamic Therapy Drugs (PTD) Market Size by Region
8.3.1 Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value by Region (2019-2030)
8.3.2 China Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
8.3.3 Japan Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
8.3.4 South Korea Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
8.3.5 India Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
8.3.7 Australia Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)

9 South America
9.1 South America Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2019-2030)
9.2 South America Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2019-2030)
9.3 South America Photodynamic Therapy Drugs (PTD) Market Size by Country
9.3.1 South America Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2019-2030)
9.3.2 Brazil Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
9.3.3 Argentina Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)

10 Middle East & Africa
10.1 Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Photodynamic Therapy Drugs (PTD) Market Size by Country
10.3.1 Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2019-2030)
10.3.2 Turkey Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)
10.3.4 UAE Photodynamic Therapy Drugs (PTD) Market Size and Forecast (2019-2030)

11 Market Dynamics
11.1 Photodynamic Therapy Drugs (PTD) Market Drivers
11.2 Photodynamic Therapy Drugs (PTD) Market Restraints
11.3 Photodynamic Therapy Drugs (PTD) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry

12 Industry Chain Analysis
12.1 Photodynamic Therapy Drugs (PTD) Industry Chain
12.2 Photodynamic Therapy Drugs (PTD) Upstream Analysis
12.3 Photodynamic Therapy Drugs (PTD) Midstream Analysis
12.4 Photodynamic Therapy Drugs (PTD) Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Photodynamic Therapy Drugs (PTD) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Photodynamic Therapy Drugs (PTD) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Photodynamic Therapy Drugs (PTD) Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Photodynamic Therapy Drugs (PTD) Consumption Value by Region (2025-2030) & (USD Million)
Table 5. DUSA Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 6. DUSA Pharmaceuticals Major Business
Table 7. DUSA Pharmaceuticals Photodynamic Therapy Drugs (PTD) Product and Solutions
Table 8. DUSA Pharmaceuticals Photodynamic Therapy Drugs (PTD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. DUSA Pharmaceuticals Recent Developments and Future Plans
Table 10. Soligenix Company Information, Head Office, and Major Competitors
Table 11. Soligenix Major Business
Table 12. Soligenix Photodynamic Therapy Drugs (PTD) Product and Solutions
Table 13. Soligenix Photodynamic Therapy Drugs (PTD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Soligenix Recent Developments and Future Plans
Table 15. ORALIA Company Information, Head Office, and Major Competitors
Table 16. ORALIA Major Business
Table 17. ORALIA Photodynamic Therapy Drugs (PTD) Product and Solutions
Table 18. ORALIA Photodynamic Therapy Drugs (PTD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Theralase Company Information, Head Office, and Major Competitors
Table 20. Theralase Major Business
Table 21. Theralase Photodynamic Therapy Drugs (PTD) Product and Solutions
Table 22. Theralase Photodynamic Therapy Drugs (PTD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 23. Theralase Recent Developments and Future Plans
Table 24. Quest Pharmatech Company Information, Head Office, and Major Competitors
Table 25. Quest Pharmatech Major Business
Table 26. Quest Pharmatech Photodynamic Therapy Drugs (PTD) Product and Solutions
Table 27. Quest Pharmatech Photodynamic Therapy Drugs (PTD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 28. Quest Pharmatech Recent Developments and Future Plans
Table 29. Biofrontera Company Information, Head Office, and Major Competitors
Table 30. Biofrontera Major Business
Table 31. Biofrontera Photodynamic Therapy Drugs (PTD) Product and Solutions
Table 32. Biofrontera Photodynamic Therapy Drugs (PTD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 33. Biofrontera Recent Developments and Future Plans
Table 34. Merck Company Information, Head Office, and Major Competitors
Table 35. Merck Major Business
Table 36. Merck Photodynamic Therapy Drugs (PTD) Product and Solutions
Table 37. Merck Photodynamic Therapy Drugs (PTD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 38. Merck Recent Developments and Future Plans
Table 39. QIYUE BIOLOGY Company Information, Head Office, and Major Competitors
Table 40. QIYUE BIOLOGY Major Business
Table 41. QIYUE BIOLOGY Photodynamic Therapy Drugs (PTD) Product and Solutions
Table 42. QIYUE BIOLOGY Photodynamic Therapy Drugs (PTD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 43. QIYUE BIOLOGY Recent Developments and Future Plans
Table 44. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Company Information, Head Office, and Major Competitors
Table 45. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Major Business
Table 46. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Photodynamic Therapy Drugs (PTD) Product and Solutions
Table 47. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Photodynamic Therapy Drugs (PTD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 48. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Recent Developments and Future Plans
Table 49. Shanghai Guangsheng Pharmaceutical Company Information, Head Office, and Major Competitors
Table 50. Shanghai Guangsheng Pharmaceutical Major Business
Table 51. Shanghai Guangsheng Pharmaceutical Photodynamic Therapy Drugs (PTD) Product and Solutions
Table 52. Shanghai Guangsheng Pharmaceutical Photodynamic Therapy Drugs (PTD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 53. Shanghai Guangsheng Pharmaceutical Recent Developments and Future Plans
Table 54. APExBIO Technology Company Information, Head Office, and Major Competitors
Table 55. APExBIO Technology Major Business
Table 56. APExBIO Technology Photodynamic Therapy Drugs (PTD) Product and Solutions
Table 57. APExBIO Technology Photodynamic Therapy Drugs (PTD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 58. APExBIO Technology Recent Developments and Future Plans
Table 59. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 60. Thermo Fisher Major Business
Table 61. Thermo Fisher Photodynamic Therapy Drugs (PTD) Product and Solutions
Table 62. Thermo Fisher Photodynamic Therapy Drugs (PTD) Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 63. Thermo Fisher Recent Developments and Future Plans
Table 64. Global Photodynamic Therapy Drugs (PTD) Revenue (USD Million) by Players (2019-2024)
Table 65. Global Photodynamic Therapy Drugs (PTD) Revenue Share by Players (2019-2024)
Table 66. Breakdown of Photodynamic Therapy Drugs (PTD) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 67. Market Position of Players in Photodynamic Therapy Drugs (PTD), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 68. Head Office of Key Photodynamic Therapy Drugs (PTD) Players
Table 69. Photodynamic Therapy Drugs (PTD) Market: Company Product Type Footprint
Table 70. Photodynamic Therapy Drugs (PTD) Market: Company Product Application Footprint
Table 71. Photodynamic Therapy Drugs (PTD) New Market Entrants and Barriers to Market Entry
Table 72. Photodynamic Therapy Drugs (PTD) Mergers, Acquisition, Agreements, and Collaborations
Table 73. Global Photodynamic Therapy Drugs (PTD) Consumption Value (USD Million) by Type (2019-2024)
Table 74. Global Photodynamic Therapy Drugs (PTD) Consumption Value Share by Type (2019-2024)
Table 75. Global Photodynamic Therapy Drugs (PTD) Consumption Value Forecast by Type (2025-2030)
Table 76. Global Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2019-2024)
Table 77. Global Photodynamic Therapy Drugs (PTD) Consumption Value Forecast by Application (2025-2030)
Table 78. North America Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2019-2024) & (USD Million)
Table 79. North America Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2025-2030) & (USD Million)
Table 80. North America Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2019-2024) & (USD Million)
Table 81. North America Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2025-2030) & (USD Million)
Table 82. North America Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2019-2024) & (USD Million)
Table 83. North America Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2025-2030) & (USD Million)
Table 84. Europe Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2019-2024) & (USD Million)
Table 85. Europe Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2025-2030) & (USD Million)
Table 86. Europe Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2019-2024) & (USD Million)
Table 87. Europe Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2025-2030) & (USD Million)
Table 88. Europe Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2019-2024) & (USD Million)
Table 89. Europe Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2025-2030) & (USD Million)
Table 90. Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2019-2024) & (USD Million)
Table 91. Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2025-2030) & (USD Million)
Table 92. Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2019-2024) & (USD Million)
Table 93. Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2025-2030) & (USD Million)
Table 94. Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value by Region (2019-2024) & (USD Million)
Table 95. Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value by Region (2025-2030) & (USD Million)
Table 96. South America Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2019-2024) & (USD Million)
Table 97. South America Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2025-2030) & (USD Million)
Table 98. South America Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2019-2024) & (USD Million)
Table 99. South America Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2025-2030) & (USD Million)
Table 100. South America Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2019-2024) & (USD Million)
Table 101. South America Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2025-2030) & (USD Million)
Table 102. Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2019-2024) & (USD Million)
Table 103. Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value by Type (2025-2030) & (USD Million)
Table 104. Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2019-2024) & (USD Million)
Table 105. Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value by Application (2025-2030) & (USD Million)
Table 106. Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2019-2024) & (USD Million)
Table 107. Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value by Country (2025-2030) & (USD Million)
Table 108. Global Key Players of Photodynamic Therapy Drugs (PTD) Upstream (Raw Materials)
Table 109. Global Photodynamic Therapy Drugs (PTD) Typical Customers


List of Figures
Figure 1. Photodynamic Therapy Drugs (PTD) Picture
Figure 2. Global Photodynamic Therapy Drugs (PTD) Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Type in 2023
Figure 4. Aminolevulinic Acid
Figure 5. Hemoporfin
Figure 6. Sinoporphyrin Sodium
Figure 7. Others
Figure 8. Global Photodynamic Therapy Drugs (PTD) Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Application in 2023
Figure 10. Pancreatic Cancer Picture
Figure 11. Esophageal Cancer Picture
Figure 12. Skin Cancer Picture
Figure 13. Lung Cancer Picture
Figure 14. Others Picture
Figure 15. Global Photodynamic Therapy Drugs (PTD) Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global Photodynamic Therapy Drugs (PTD) Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global Market Photodynamic Therapy Drugs (PTD) Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
Figure 18. Global Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Region (2019-2030)
Figure 19. Global Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Region in 2023
Figure 20. North America Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 21. Europe Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 22. Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 23. South America Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 24. Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 25. Company Three Recent Developments and Future Plans
Figure 26. Global Photodynamic Therapy Drugs (PTD) Revenue Share by Players in 2023
Figure 27. Photodynamic Therapy Drugs (PTD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
Figure 28. Market Share of Photodynamic Therapy Drugs (PTD) by Player Revenue in 2023
Figure 29. Top 3 Photodynamic Therapy Drugs (PTD) Players Market Share in 2023
Figure 30. Top 6 Photodynamic Therapy Drugs (PTD) Players Market Share in 2023
Figure 31. Global Photodynamic Therapy Drugs (PTD) Consumption Value Share by Type (2019-2024)
Figure 32. Global Photodynamic Therapy Drugs (PTD) Market Share Forecast by Type (2025-2030)
Figure 33. Global Photodynamic Therapy Drugs (PTD) Consumption Value Share by Application (2019-2024)
Figure 34. Global Photodynamic Therapy Drugs (PTD) Market Share Forecast by Application (2025-2030)
Figure 35. North America Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Type (2019-2030)
Figure 36. North America Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Application (2019-2030)
Figure 37. North America Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 39. Canada Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 40. Mexico Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 41. Europe Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Type (2019-2030)
Figure 42. Europe Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Application (2019-2030)
Figure 43. Europe Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 45. France Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 46. United Kingdom Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 47. Russia Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 48. Italy Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Region (2019-2030)
Figure 52. China Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 53. Japan Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 54. South Korea Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 55. India Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 56. Southeast Asia Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 57. Australia Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 58. South America Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Type (2019-2030)
Figure 59. South America Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Application (2019-2030)
Figure 60. South America Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Country (2019-2030)
Figure 61. Brazil Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 62. Argentina Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 63. Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Type (2019-2030)
Figure 64. Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Application (2019-2030)
Figure 65. Middle East & Africa Photodynamic Therapy Drugs (PTD) Consumption Value Market Share by Country (2019-2030)
Figure 66. Turkey Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 67. Saudi Arabia Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 68. UAE Photodynamic Therapy Drugs (PTD) Consumption Value (2019-2030) & (USD Million)
Figure 69. Photodynamic Therapy Drugs (PTD) Market Drivers
Figure 70. Photodynamic Therapy Drugs (PTD) Market Restraints
Figure 71. Photodynamic Therapy Drugs (PTD) Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Photodynamic Therapy Drugs (PTD) Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

DUSA Pharmaceuticals
Soligenix
ORALIA
Theralase
Quest Pharmatech
Biofrontera
Merck
QIYUE BIOLOGY
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
Shanghai Guangsheng Pharmaceutical
APExBIO Technology
Thermo Fisher
jiaGou

Add To Cart

gouMai

Buy Now